Skip to content

GPR Clinic introduces new procedure for sepsis therapy

Share on facebook
Share on twitter
Share on linkedin

The Department of Anaesthesiology, Anesthesiological Intensive Care and Perioperative Pain Management under the direction of Privatdozent Dr. med. med. Gerd Albuszies, MBA in the GPR Clinic, is now using a new therapy method in the intensive care unit of the GPR Clinic, which is used in a massive inflammatory reaction of the body (inflammatory cytokine release) in sepsis.

About us

Cytosorbents Europe GmbH, headquartered in Berlin, is a wholly owned subsidiary of CytoSorbents Corporation of Monmouth Junction, New Jersey, USA, where the CytoSorb product is manufactured. CytoSorb is the company’s flagship product, backed by more than 30 patent families.

More in the press

Follow us

CytoSorb User´s Meeting

Play Video

Subscribe to our newsletter now!

Get access to the CytoSorbents Community Area. The current newsletter contains a direct link to the CytoSorbents Community Area.

Help us direct you to the right information by selecting the option that best describes you:

You are trying to enter content on the international website of CytoSorbents Europe with a US IP address.

* I am aware that the content provided on this website is in accordance with the European CE label of CytoSorb and that the CytoSorb device has neither been cleared or approved by the FDA.

You are trying to enter our US website with a non-US IP address.

This website is only for healthcare professionals in the USA.

* I am aware that the content provided on this website is in accordance with the Emergency Use Authorization (EUA) for use in critically-ill COVID-19 patients with imminent or confirmed respiratory failure, in defined circumstances, issued by the American FDA and that this EUA differs from the CE label.

You are trying to enter our international website with a US IP address.

This website is only for healthcare professionals outside the USA.

* I am aware that the content provided on this website is in accordance with the European CE label of CytoSorb and that the CytoSorb device has neither been cleared or approved by the FDA.

This website is only for healthcare professionals outside the USA.

Help us direct you to the right information by selecting the option that best describes you: